INTRODUCTION: The aim of our analysis is to assess gender differences in baseline characteristics, acute therapies, and clinical outcome in patients with acute ST-elevation myocardial infarction (STEMI) complicated by cardiogenic shock. METHODS: The Maximal Individual Therapy of Acute Myocardial Infarction PLUS registry (MITRA PLUS) is a German prospective, multicenter, observational data pool of current treatment of STEMI. RESULTS: STEMI was more often (P < 0.0001) complicated by cardiogenic shock in female patients (12.9%) when compared to male patients (9.3%). This was still true after adjusting for confounding variables (OR 1.19, 95% CI 1.09-1.30). Women with STEMI admitted in a cardiogenic shock were older (P < 0.0001) and had more often concomitant diseases (P < 0.0001). There was no differences in rates of reperfusion therapy (OR 0.92, 95% CI 0.77-1.09). Hospital mortality was 67.7% in female patients, when compared to 57.2% in male patients (P < 0.0001). After adjusting for confounding variables in the multivariate analysis hospital mortality did not differ between men and women (OR 1.16, 95% CI 0.98-1.38). Early reperfusion therapy was associated with a significant reduction of hospital mortality in female patients with STEMI complicated by cardiogenic shock (OR 0.68, 95% CI 0.52-0.90) with primary PCI being more effective than thrombolytic therapy (OR 0.46, 95% CI 0.31-0.68). CONCLUSION: In women, STEMI was more often complicated by cardiogenic shock when compared to men. However, the use of early reperfusion therapy did not differ between the sexes. Primary PCI was associated with the best outcome in female patients with STEMI complicated by cardiogenic shock and is therefore the therapy of choice.
INTRODUCTION: The aim of our analysis is to assess gender differences in baseline characteristics, acute therapies, and clinical outcome in patients with acute ST-elevation myocardial infarction (STEMI) complicated by cardiogenic shock. METHODS: The Maximal Individual Therapy of Acute Myocardial Infarction PLUS registry (MITRA PLUS) is a German prospective, multicenter, observational data pool of current treatment of STEMI. RESULTS: STEMI was more often (P < 0.0001) complicated by cardiogenic shock in female patients (12.9%) when compared to male patients (9.3%). This was still true after adjusting for confounding variables (OR 1.19, 95% CI 1.09-1.30). Women with STEMI admitted in a cardiogenic shock were older (P < 0.0001) and had more often concomitant diseases (P < 0.0001). There was no differences in rates of reperfusion therapy (OR 0.92, 95% CI 0.77-1.09). Hospital mortality was 67.7% in female patients, when compared to 57.2% in male patients (P < 0.0001). After adjusting for confounding variables in the multivariate analysis hospital mortality did not differ between men and women (OR 1.16, 95% CI 0.98-1.38). Early reperfusion therapy was associated with a significant reduction of hospital mortality in female patients with STEMI complicated by cardiogenic shock (OR 0.68, 95% CI 0.52-0.90) with primary PCI being more effective than thrombolytic therapy (OR 0.46, 95% CI 0.31-0.68). CONCLUSION: In women, STEMI was more often complicated by cardiogenic shock when compared to men. However, the use of early reperfusion therapy did not differ between the sexes. Primary PCI was associated with the best outcome in female patients with STEMI complicated by cardiogenic shock and is therefore the therapy of choice.
Authors: R M Steingart; M Packer; P Hamm; M E Coglianese; B Gersh; E M Geltman; J Sollano; S Katz; L Moyé; L L Basta Journal: N Engl J Med Date: 1991-07-25 Impact factor: 91.245
Authors: S Schuster; A Koch; U Burczyk; R Schiele; H G Glunz; T Voigtländer; P Limbourg; K Stuby; G Berg; U Gieseler; M Jakob; P Hauptmann; J Senges Journal: Z Kardiol Date: 1999-10
Authors: Tobias Heer; Rudolf Schiele; Steffen Schneider; Anselm K Gitt; Harm Wienbergen; Martin Gottwik; Ulf Gieseler; Thomas Voigtländer; Karl E Hauptmann; Stefan Wagner; Jochen Senges Journal: Am J Cardiol Date: 2002-03-01 Impact factor: 2.778
Authors: Christoph Liebetrau; Sebastian Szardien; Johannes Rixe; Mariella Woelken; Andreas Rolf; Timm Bauer; Holger Nef; Helge Möllmann; Christian Hamm; Michael Weber Journal: Clin Res Cardiol Date: 2010-09-21 Impact factor: 5.460
Authors: Michael Ried; Dirk Lunz; Reinhard Kobuch; Leopold Rupprecht; Andreas Keyser; Michael Hilker; Christof Schmid; Claudius Diez Journal: Clin Res Cardiol Date: 2012-01-08 Impact factor: 5.460
Authors: Karl Fengler; Georg Fuernau; Steffen Desch; Ingo Eitel; Franz-Josef Neumann; Hans-Georg Olbrich; Antoinette de Waha; Suzanne de Waha; Gert Richardt; Marcus Hennersdorf; Klaus Empen; Rainer Hambrecht; Jörg Fuhrmann; Michael Böhm; Janine Poess; Ruth Strasser; Steffen Schneider; Gerhard Schuler; Karl Werdan; Uwe Zeymer; Holger Thiele Journal: Clin Res Cardiol Date: 2014-10-07 Impact factor: 5.460
Authors: Liliana Kiczak; Alicja Tomaszek; Urszula Pasławska; Jacek Bania; Agnieszka Noszczyk-Nowak; Piotr Skrzypczak; Robert Pasławski; Maciej Zacharski; Adrian Janiszewski; Piotr Kuropka; Piotr Ponikowski; Ewa A Jankowska Journal: Biol Sex Differ Date: 2015-12-10 Impact factor: 5.027
Authors: Amber M Otten; Jan Paul Ottervanger; Jorik R Timmer; Arnoud Wj van 't Hof; Jan-Henk E Dambrink; At Marcel Gosselink; Jan Ca Hoorntje; Harry Suryapranata; Angela Hem Maas Journal: Diabetol Metab Syndr Date: 2013-07-04 Impact factor: 3.320